This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi of lower limb, including hip
CD2_BENIGN_MELANOCYTIC_LOWERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) coxae
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of lower limb, including hip
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1622 | 1117 | 505 |
| Unadjusted period prevalence (%) | 0.33 | 0.38 | 0.22 |
| Median age at first event (years) | 51.29 | 48.10 | 58.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1428
- Matched controls
- 14278
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
109.5
323.0
622
100
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
5079.9
323.0
1350
50
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
14.3
253.3
465
465
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
15.3
196.2
342
287
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
11.4
162.0
325
359
PJA12
NOMESCO Finland
Sentinel node biopsy
436.8
159.7
157
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
148.9
128.6
135
10
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
13.3
127.4
233
206
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
12.9
119.5
221
199
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
10.0
105.3
222
257
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
103.4
98
*
L57.0
ICD-10 Finland
Actinic keratosis
7.2
87.6
229
370
2167A
ICD-9 Finland
Benign neoplasm of skin, Skin of lower limb, including hip[ALARAAJAN IHON BEN KASV,NAEVUS PIGMENTOSUS]
+∞
85.3
81
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
154.2
83.0
87
6
115
Kela drug reimbursment
Breast cancer
+∞
73.6
70
*
TQW99
NOMESCO Finland
Other minor procedure on skin
9.6
71.9
153
176
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.0
71.8
328
983
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
70.4
67
*
130
Kela drug reimbursment
Malignant tumour
+∞
69.3
66
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
16.3
68.6
113
75
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
65.1
62
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
65.1
62
*
XQ845
NOMESCO Finland
Dermatoscopy
29.9
60.8
82
29
C61
ICD-10 Finland
Malignant neoplasm of prostate
613.0
60.2
59
*
XQ848
NOMESCO Finland
Dermatological photography
12.9
58.0
105
87
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
56.6
54
*
S18
ICPC
Laceration/cut
2.5
54.8
642
3535
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
53.5
51
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
25.6
52.0
73
30
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
14.9
50.8
86
61
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
49.2
47
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
48.2
46
*
H02AB02
ATC
dexamethasone; systemic
13.4
45.2
80
63
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
101.4
45.1
49
5
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
45.0
43
*
ZZR00
NOMESCO Finland
Flap of skin
41.6
45.0
56
14
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
30.7
44.3
59
20
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
44.0
42
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
42.9
41
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.0
41.0
278
1078
A04AA02
ATC
granisetron; systemic, transdermal
147.7
41.0
43
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
13.5
40.4
71
55
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
408.6
40.3
40
*
9733
FHL
Excision of skin change in operating room or anesthesia
12.6
39.7
72
60
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
140.6
38.9
41
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
37.7
36
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
37.7
36
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
376.8
37.2
37
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
36.1
118
245
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
35.6
34
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
35.6
34
*
L02BA01
ATC
tamoxifen; oral
68.4
35.1
40
6
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
34.5
33
*
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
179.2
33.9
35
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
11.3
33.7
64
59
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
334.5
33.0
33
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
334.5
33.0
33
*
HAC20
NOMESCO Finland
Total mastectomy
92.3
32.9
36
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
12.3
31.4
57
48
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
163.5
30.8
32
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
84.5
29.8
33
*
ZXC50
NOMESCO Finland
Cryotherapy
8.3
29.3
66
83
127
Kela drug reimbursment
Transplant complication
10.4
28.8
57
57
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
30.0
28.6
38
13
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
15.8
28.3
46
30
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
28.2
27
*
SPAT1153
SPAT
Removal of sutures
2.0
26.7
432
2540
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
26.1
25
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
26.1
25
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
26.0
229
1018
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
95.2
25.7
28
*
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
6.7
25.5
66
103
L04AA06
ATC
mycophenolic acid; systemic
7.6
25.4
60
82
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
25.1
24
*
Z2221
NOMESCO Finland
Medical doctor
2.0
24.9
432
2593
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
71.2
24.9
28
*
S77
ICPC
Malignant neoplasm of skin
91.7
24.7
27
*
ZQZ00
NOMESCO Finland
Treatment of several skin areas
68.6
23.9
27
*
ZZA00
NOMESCO Finland
Split skin graft
7.0
23.7
59
87
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
243.9
23.7
24
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
23.5
489
3122
D22
ICD-10 Finland
Melanocytic naevi
3.7
23.2
105
299
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.8
22.8
39
29
ZX090
NOMESCO Finland
Other technic of radiotherapy
233.6
22.7
23
*
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
10.5
22.7
44
43
C50.99
ICD-10 Finland
Breast, unspecified
122.0
22.6
24
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
122.0
22.6
24
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
19.8
22.2
33
17
L03AA13
ATC
pegfilgrastim; parenteral
+∞
21.9
21
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
21.9
21
*
S82
ICPC
Naevus/mole
2.3
21.0
208
977
116
Kela drug reimbursment
Prostate cancer
+∞
20.9
20
*
L01BC06
ATC
capecitabine; oral
+∞
20.9
20
*
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
20.9
20
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
20.9
20
*
ZXC20
NOMESCO Finland
Use of chemical agents
8.9
20.7
44
51
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
20.7
524
3536
ZXA05
NOMESCO Finland
Left side
2.0
20.5
328
1887
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
19.8
19
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
19.8
19
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
6.0
19.5
54
93
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
18.8
18
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
18.8
18
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
18.8
18
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
18.8
18
*
HA1AA
NOMESCO Finland
X-ray mammography
4.0
18.8
77
202
E0000UV
ATC
NA
1.7
18.6
557
3917
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
101.4
18.6
20
*
Z94.0
ICD-10 Finland
Kidney transplant status
8.5
18.5
40
48
A04AA01
ATC
ondansetron; systemic, rectal
4.4
17.9
65
152
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
17.7
17
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.0
17.7
37
42
WF002
NOMESCO Finland
Radical radiotherapy
29.2
17.4
23
8
L03AA02
ATC
filgrastim; parenteral
42.5
17.3
21
5
L04AX01
ATC
azathioprine; systemic
3.4
16.8
82
249
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.5
16.7
32
31
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
16.7
16
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
16.7
16
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
16.7
16
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
16.7
16
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
16.7
16
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.7
16
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.9
16.7
33
34
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
16.6
345
2157
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
16.6
397
2596
C43
ICD-10 Finland
Malignant melanoma of skin
171.9
16.5
17
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.6
16.4
74
211
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
16.2
78
235
L04AD01
ATC
ciclosporin; systemic
6.0
16.1
44
75
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
5.5
16.0
47
88
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
60.7
15.8
18
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
15.6
15
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
15.6
15
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
15.6
15
*
ZXA00
NOMESCO Finland
Right side
1.8
15.6
330
2066
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
26.6
15.6
21
8
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.9
15.6
28
24
C50
ICD-10 Finland
Malignant neoplasm of breast
161.7
15.5
16
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
161.7
15.5
16
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
161.7
15.5
16
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
161.7
15.5
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
15.4
262
1527
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
38.5
15.4
19
5
TQW80
NOMESCO Finland
Local dermatologic skincare
4.7
15.2
52
115
NK6AN
NOMESCO Finland
Total body bone isotope imaging
28.9
15.2
20
7
ZXE00
NOMESCO Finland
One hour or less
1.6
15.0
523
3771
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
14.6
14
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
14.6
14
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
14.6
14
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
80.9
14.6
16
*
A04AA55
ATC
palonosetron, combinations; systemic
151.5
14.5
15
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
36.4
14.5
18
5
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
27.5
14.3
19
7
L04AA01
ATC
[U] ciclosporin; systemic
6.2
14.3
38
63
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
19.3
14.2
21
11
S21
ICPC
Skin texture symptom/complaint
2.1
14.2
175
898
B07.9
ICD-10 Finland
Verruca simplex
3.5
14.1
66
195
ZX120
NOMESCO Finland
Intravenous
2.6
14.0
106
431
Z3231
NOMESCO Finland
Registered nurse
1.7
14.0
347
2272
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
14.0
157
775
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
30.3
13.9
18
6
R4110
NOMESCO Finland
Physiotherapy
1.7
13.6
320
2061
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
13.6
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.6
13
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
13.6
13
*
D06BB10
ATC
imiquimod; topical
3.2
13.3
70
227
UJF32
NOMESCO Finland
Coloscopy
1.7
13.2
300
1913
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.0
13.1
29
37
WX402
NOMESCO Finland
General anaesthesia
1.9
12.7
193
1078
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
15.6
12.6
20
13
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
70.5
12.6
14
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.5
12
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
12.5
12
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
12.5
12
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
12.5
12
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
12.5
12
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
131.1
12.5
13
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.1
12.3
70
237
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
12.2
494
3646
J01DB01
ATC
cefalexin; oral
1.6
12.1
1123
9965
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
5.3
12.1
36
69
DAB00
NOMESCO Finland
Excision of lesion of auricle
12.5
12.1
21
17
DHB00
NOMESCO Finland
Excision of lesion of external nose
26.9
12.1
16
6
A11CC03
ATC
alfacalcidol; systemic
4.2
11.9
44
107
R50.9
ICD-10 Finland
Fever, unspecified
2.0
11.8
164
884
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
11.7
244
1510
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.4
11.7
30
48
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
16.6
11.7
18
11
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
11.5
11
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
+∞
11.5
11
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.5
11
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
120.9
11.4
12
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
15.2
11.3
18
12
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
7.7
11.2
25
33
PJA10
NOMESCO Finland
Exploration of lymph nodes
20.2
11.1
16
8
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
4.0
11.1
43
109
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.9
11.1
44
114
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.1
350
2427
B01AB05
ATC
enoxaparin; parenteral
1.6
11.1
317
2143
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.1
11.0
41
101
Z51.5
ICD-10 Finland
Palliative care
5.2
10.9
33
65
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.8
10.9
30
53
B03XA01
ATC
erythropoietin; parenteral
10.7
10.8
20
19
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.9
10.8
22
25
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
18.0
10.7
16
9
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
28.2
10.7
14
5
A04AD12
ATC
aprepitant; systemic
60.4
10.6
12
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
60.4
10.6
12
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
10.6
68
253
D18.0
ICD-10 Finland
Haemangioma, any site
4.1
10.5
39
96
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
110.8
10.4
11
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
10.4
10
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
L02BG06
ATC
exemestane; oral
+∞
10.4
10
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
10.4
10
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
10.2
231
1463
S29
ICPC
Skin symptom/complaint other
1.7
10.1
209
1287
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
10.1
306
2094
JN4CD
NOMESCO Finland
Very extensive body CT
4.7
10.0
33
72
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
10.0
87
384
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.8
10.0
32
68
L04AA05
ATC
[U] tacrolimus; systemic
40.4
10.0
12
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
9.9
71
282
N02BE01
ATC
paracetamol; systemic, rectal
1.5
9.8
1135
10242
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
8.4
9.6
20
24
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.7
9.6
65
251
A12AA04
ATC
calcium carbonate; oral
4.7
9.5
31
67
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
5.7
9.5
26
46
D06BX02
ATC
ingenol mebutate; topical
7.2
9.5
22
31
137
Kela drug reimbursment
Uraemia requiring dialysis
6.7
9.4
23
35
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
100.7
9.4
10
*
X76
ICPC
Malignant neoplasm breast female
100.7
9.4
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
30.2
9.4
12
*
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
30.2
9.4
12
*
L02BG03
ATC
anastrozole; oral
30.2
9.4
12
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
C44
ICD-10 Finland
Other malignant neoplasms of skin
+∞
9.4
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
+∞
9.4
9
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
9.4
9
*
180
Kela drug reimbursment
Interferon alfa
+∞
9.4
9
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.4
9.4
27
51
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.4
450
3406
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.1
9.3
35
88
N02AA05
ATC
oxycodone; systemic
2.1
9.2
108
545
Z3226
NOMESCO Finland
Physiotherapist
1.7
9.1
221
1422
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.2
9.1
46
147
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
9.1
43
131
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
9.1
75
323
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
9.1
9.0
18
20
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
9.0
74
318
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.8
8.9
24
42
UKC02
NOMESCO Finland
Cystoscopy
1.8
8.9
151
872
B03XA02
ATC
darbepoetin alfa; parenteral
4.8
8.9
28
59
B01AB10
ATC
tinzaparin; parenteral
2.6
8.8
61
240
L91.0
ICD-10 Finland
Hypertrophic scar
4.4
8.7
30
69
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
8.7
232
1531
ZXA10
NOMESCO Finland
Bilateral
1.6
8.7
220
1434
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
8.7
52
187
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
8.7
126
692
D22.0
ICD-10 Finland
Melanocytic naevi of lip
11.6
8.6
15
13
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
16.4
8.6
13
8
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.0
8.6
20
29
D70.82
ICD-10 Finland
Drug-induced neutropenia
20.1
8.5
12
6
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
90.6
8.4
9
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
90.6
8.4
9
*
128
Kela drug reimbursment
Cancers of female genital organs
90.6
8.4
9
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.3
8
*
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
+∞
8.3
8
*
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
+∞
8.3
8
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.3
8
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
+∞
8.3
8
*
L01AX03
ATC
temozolomide; systemic
+∞
8.3
8
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
+∞
8.3
8
*
XKD00
NOMESCO Finland
Uroflowmetry
1.9
8.3
121
665
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
3.6
8.3
35
98
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.0
8.2
25
51
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
14.6
8.2
13
9
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
7.6
8.2
18
24
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
3.0
8.2
45
154
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.4
8.2
23
43
TQW20
NOMESCO Finland
Tatoe
33.5
8.1
10
*
QDE15
NOMESCO Finland
Excision of other superficial lesion of skin in lower limb
33.5
8.1
10
*
Z94.4
ICD-10 Finland
Liver transplant status
11.8
8.1
14
12
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
22.1
8.0
11
5
TQW40
NOMESCO Finland
Remowal of suture of skin
2.1
7.9
89
443
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
5.7
7.8
21
37
UJH02
NOMESCO Finland
Anoscopy
2.6
7.8
57
229
L02BG04
ATC
letrozole; oral
3.1
7.7
41
137
QDE00
NOMESCO Finland
Excision of loose skin or fold of skin from lower limb
45.2
7.7
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
7.7
103
549
Z2446
NOMESCO Finland
Social worker
2.1
7.7
83
406
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
25.1
7.6
10
*
QBA10
NOMESCO Finland
Incision of skin of trunk
5.8
7.5
20
35
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.9
7.5
44
157
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
80.5
7.4
8
*
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
80.5
7.4
8
*
A79
ICPC
Malignancy NOS
80.5
7.4
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
80.5
7.4
8
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
80.5
7.4
8
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
7.4
88
448
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.1
7.4
27
67
5AB14
NOMESCO Finland
NA
13.4
7.4
12
9
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.4
324
2393
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.8
7.3
23
49
J02AC01
ATC
fluconazole; systemic
1.4
7.3
548
4455
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
7.3
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
7.3
7
*
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
7.3
7
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
7.3
7
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
7.3
7
*
C43.74
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip acral
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
7.3
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
+∞
7.3
7
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
7.3
7
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.3
460
3634
ZX108
NOMESCO Finland
Inhalation
9.4
7.3
14
15
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.3
220
1497
ZX112
NOMESCO Finland
Subcutaneous
6.3
7.2
18
29
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.8
7.2
19
33
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
30.2
7.2
9
*
Z31.5
ICD-10 Finland
Genetic counselling
2.3
7.1
65
295
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.1
7.1
36
117
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
6.6
7.1
17
26
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.1
7.1
18
30
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
8.8
7.1
14
16
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
7.0
36
118
JN4AD
NOMESCO Finland
Body CT examination
2.7
7.0
46
176
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.2
7.0
25
61
TK800
NOMESCO Finland
Hemodialysis
3.3
7.0
33
102
WX702
NOMESCO Finland
Supraglottic ventilation device
2.2
7.0
64
292
S26
ICPC
Fear of cancer of skin
5.5
6.9
19
35
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
7.6
6.9
15
20
ZXC96
NOMESCO Finland
Robot assisted procedure
8.3
6.8
14
17
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
40.2
6.8
8
*
7151
FHL
Kidney transplantation
40.2
6.8
8
*
9734
FHL
Excision and local plastic or associated free skin grafting
7.2
6.7
15
21
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
6.7
93
505
ZZA50
NOMESCO Finland
Full thickness skin graft
22.6
6.7
9
*
S08
ICPC
Skin colour change
2.3
6.6
57
253
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.3
6.6
31
96
TQB05
NOMESCO Finland
Puncture of skin of trunk
10.1
6.5
12
12
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.3
6.5
18
34
4056
NOMESCO Finland
NA
70.1
6.4
7
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
70.1
6.4
7
*
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
7.4
6.4
14
19
HA1HA
NOMESCO Finland
Tomosynthesis mammography
14.4
6.4
10
7
QDA10
NOMESCO Finland
Incision of skin of lower limb
8.2
6.3
13
16
XJH00
NOMESCO Finland
Transanal ultrasonography
2.4
6.3
48
200
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
3.3
6.3
29
89
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.3
123
745
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
6.3
6
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
6.3
6
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
6.3
6
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
6.3
6
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
6.3
6
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
6.3
6
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
6.3
6
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
6.2
113
670
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.2
6.2
30
95
D02AE01
ATC
carbamide; topical
1.9
6.2
83
444
WX110
NOMESCO Finland
Local anesthesy
1.3
6.2
890
7922
B05DA
ATC
Isotonic solutions
5.8
6.1
16
28
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.6
6.1
12
14
N18.0
ICD-10 Finland
End-stage renal disease
4.4
6.0
20
46
D01AE16
ATC
amorolfine; topical
1.7
6.0
129
801
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
465
1107
5.49
191.13
1.8
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
961
4559
3.72
146.52
3.4
1.7
—
—
—
0
0
(4035726)
238
383
7.11
145.19
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
172
459
4.07
57.54
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
160
525
3.27
38.93
3.8
1.5
ug/l
3.3
3.3
0.03
128
394
(3013650) Neutrophils [#/volume] in Blood by Automated count
973
7091
1.93
35.28
11.5
6.7
e9/l
4.0
4.1
1.35
867
6153
(3024561) Albumin [Mass/volume] in Serum or Plasma
707
4812
1.83
30.07
6.8
3.8
g/l
36.7
36.4
0.79
655
4447
(3006315) Basophils [#/volume] in Blood
884
6457
1.81
29.57
8.6
5.5
e9/l
0.0
0.0
1.01
782
5610
(3001604) Monocytes [#/volume] in Blood
879
6431
1.80
29.03
8.6
5.5
e9/l
0.5
0.6
0.91
780
5592
(3013115) Eosinophils [#/volume] in Blood
906
6695
1.80
28.86
8.7
5.7
e9/l
0.2
0.2
0.76
803
5915
(3019198) Lymphocytes [#/volume] in Blood
899
6651
1.79
28.30
8.6
5.5
e9/l
1.9
1.9
0.21
812
5882
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
218
1003
2.36
27.34
7.8
3.2
u/l
225.4
230.9
0.38
210
942
(3010375) cycloSPORINE [Mass/volume] in Blood
37
47
8.03
27.32
24.8
27.0
ug/l
86.3
127.4
3.03
29
39
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1170
9444
1.86
26.71
10.2
5.3
u/l
75.9
74.5
0.67
1109
8796
(42870588) Differential panel, method unspecified - Blood
607
4079
1.78
25.91
8.8
5.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
788
5712
1.74
25.70
9.0
5.5
mmol/l
1.2
1.2
0.10
678
4871
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
794
5771
1.74
25.62
8.1
3.7
umol/l
11.7
11.2
0.32
755
5390
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
14
15.92
25.42
8.6
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
624
4277
1.75
24.53
5.3
3.3
e6/l
74.3
90.1
0.17
434
2872
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
342
1951
1.95
24.39
3.1
2.4
e6/l
2.2
1.1
0.42
210
1087
(3030467) Casts [#/volume] in Urine by Automated count
495
3186
1.80
24.10
4.4
2.8
e6/l
0.2
0.4
1.44
375
2362
(3018418) pH of Serum or Plasma
508
3301
1.78
23.91
6.7
3.1
ph
7.4
7.4
0.56
80
552
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
715
5130
1.70
23.53
7.9
5.1
mmol/l
1.2
1.2
0.20
661
4587
(40758558) Short blood count panel - Blood
468
3003
1.78
22.80
9.0
4.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
552
3775
1.70
21.13
4.4
2.0
mmol/l
2.4
2.4
0.03
485
3239
(3033658) Prothrombin time (PT) actual/Normal
453
2934
1.75
21.10
5.3
3.3
%
91.4
92.5
0.41
439
2843
(36304419) Bacteria [Presence] in Urine
476
3143
1.73
20.63
4.4
2.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
67
190
3.64
20.38
10.3
5.3
iu/ml
3786.8
377.9
0.43
12
23
(3020779) Urea [Moles/volume] in Serum or Plasma
182
878
2.21
20.18
11.8
6.7
mmol/l
10.1
9.2
0.87
176
843
(3012095) Magnesium [Moles/volume] in Serum or Plasma
284
1614
1.92
20.15
5.0
2.8
mmol/l
0.8
0.8
0.43
262
1489
(3002582) Erythrocytes [#/volume] in Urine
512
3478
1.69
19.84
4.7
2.8
e6/l
27.5
80.0
1.53
399
2626
(3022096) Basophils/100 leukocytes in Blood
768
5790
1.62
19.66
9.1
5.7
%
0.7
0.7
1.58
714
5394
(3006504) Eosinophils/100 leukocytes in Blood
789
5992
1.62
19.57
9.0
5.6
%
2.8
2.9
0.50
733
5576
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
304
1789
1.86
19.30
3.6
2.5
e6/l
3.3
3.2
0.06
172
925
(3019069) Monocytes/100 leukocytes in Blood
790
6020
1.61
19.18
9.2
5.8
%
8.3
8.3
0.14
738
5638
(40768793) Breast Pathology biopsy report
48
112
4.39
19.06
1.2
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
810
6222
1.60
18.93
9.0
5.7
%
28.6
29.0
0.59
757
5805
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
28
8.69
18.92
2.7
2.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
801
6161
1.59
18.44
8.7
5.5
%
56.9
56.8
0.11
747
5769
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
15
12.12
17.82
1.2
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
724
5498
1.57
17.20
2.7
2.3
nmol/l
78.2
76.5
0.96
666
4962
(3000850) Epithelial cells [#/volume] in Urine
372
2418
1.70
16.54
3.8
2.3
e6/l
5.6
7.0
1.02
334
2096
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
202
3.26
16.53
4.3
2.1
u/ml
111.1
71.9
0.21
50
159
(3044640) Blood type and Crossmatch panel - Blood
509
3584
1.61
16.53
2.4
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1304
11440
1.71
16.19
20.7
13.0
%
13.5
13.5
0.28
1285
11158
(3013707) Erythrocyte sedimentation rate by Westergren method
1151
9845
1.58
15.19
5.1
4.0
mm/h
10.4
10.7
0.43
1075
9143
(3007853) Bacteria identified in Skin by Aerobe culture
243
1431
1.82
15.14
2.3
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1023
8531
1.54
15.04
4.9
4.1
e6/l
3705.1
2203.4
—
9
108
(3003458) Phosphate [Moles/volume] in Serum or Plasma
241
1429
1.81
14.66
9.7
5.1
mmol/l
1.1
1.0
0.52
231
1320
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
564
4164
1.54
14.51
4.6
2.7
u/l
28.8
30.7
1.05
539
3966
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
728
5685
1.51
14.35
4.1
3.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
585
4366
1.53
14.27
9.0
8.0
inr
1.1
1.2
1.64
155
1317
(3021589) Normoblasts [#/volume] in Blood
730
5722
1.50
14.03
12.2
7.7
e9/l
0.0
0.0
0.48
607
4660
(40768795) Lymph node Pathology biopsy report
20
27
7.49
13.99
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
54
5.26
13.93
2.1
2.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
33
74
4.53
13.80
6.1
1.1
u/ml
33.2
195.0
0.83
11
19
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
312
2024
1.67
13.71
3.8
2.1
mmol/l
2.4
2.4
0.36
271
1742
(3022145) Colonoscopy Study observation
213
1259
1.80
13.02
1.5
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
1051
8958
1.49
12.79
3.9
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
213
1271
1.78
12.60
4.5
2.1
umol/l
8.4
6.4
1.05
191
1076
(3023368) Bacteria identified in Blood by Culture
385
2680
1.57
12.57
5.1
3.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
18
9
20.21
12.46
4.9
1.0
u/ml
48.3
15.5
—
18
9
(3026782) Osmolality of Urine
330
2224
1.61
12.34
4.2
2.4
mosm/kgh2o
526.2
541.8
0.70
285
1863
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
234
1444
1.73
12.29
3.9
2.5
%
23.6
24.1
0.25
215
1236
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
391
2748
1.56
12.19
2.4
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1062
9116
1.48
12.11
5.3
4.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
275
1785
1.65
11.93
3.6
2.3
umol/l
13.6
14.1
0.53
265
1639
(3020630) Protein [Mass/volume] in Serum or Plasma
147
797
1.93
11.78
2.7
1.5
g/l
66.3
67.4
1.03
141
724
(3011397) Hemoglobin [Presence] in Urine by Test strip
427
3080
1.52
11.77
3.7
3.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
251
1601
1.67
11.63
3.7
2.3
g/l
2.3
2.4
1.20
241
1486
(3009261) Glucose [Presence] in Urine by Test strip
809
6640
1.44
11.39
4.0
3.4
estimate
0.0
0.0
1.32
131
1133
(3019550) Sodium [Moles/volume] in Serum or Plasma
1468
13618
1.82
11.35
17.9
12.3
mmol/l
139.7
139.7
0.14
1442
13243
(3021601) Nitrite [Presence] in Urine by Test strip
801
6571
1.43
11.26
5.6
4.6
estimate
0.0
0.0
0.50
136
1170
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
156
876
1.86
11.23
6.0
3.8
ng/l
101.7
82.2
1.18
144
773
(3035350) Ketones [Presence] in Urine by Test strip
797
6538
1.43
11.17
4.0
3.3
estimate
0.0
0.0
0.00
132
1147
(3018677) aPTT in Platelet poor plasma by Coagulation assay
258
1679
1.64
11.03
2.5
2.0
s
29.4
29.7
0.34
250
1618
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
135
728
1.93
10.99
1.7
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
229
1447
1.68
10.97
1.9
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
362
2.30
10.78
2.4
1.4
g/l
9.9
10.4
0.69
73
310
(3026493) Urate [Moles/volume] in Serum or Plasma
431
3165
1.49
10.75
3.7
2.2
umol/l
3336.8
5474.4
0.57
381
2759
(40768446) Kidney Pathology biopsy report
21
40
5.31
10.60
1.8
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1468
13663
1.78
10.59
18.3
12.4
mmol/l
3.9
4.0
2.36
1442
13260
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
15
8.73
10.24
5.1
7.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1212
10821
1.47
10.20
4.7
4.1
pmol/l
14.7
14.6
0.47
1128
9996
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
60
243
2.53
9.92
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
49
180
2.78
9.82
1.4
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
390
2.19
9.82
2.3
1.4
g/l
7.0
7.4
1.52
67
300
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
390
2.19
9.82
2.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
390
2.19
9.82
2.3
1.4
g/l
3.9
3.8
0.11
67
287
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1446
13455
1.69
9.74
17.3
10.8
mg/l
21.1
21.0
0.03
1103
10270
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
179
1096
1.71
9.60
2.8
2.1
u/l
34.7
39.0
0.42
159
915
(3004588) Protein electrophoresis panel - Serum or Plasma
123
677
1.88
9.42
2.5
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
73
332
2.26
9.36
2.8
1.4
g/l
0.7
0.3
0.40
66
295
(3042936) Bacteria identified in Isolate by Culture
237
1570
1.60
9.34
2.2
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
152
897
1.77
9.29
3.4
2.4
g/l
10.1
10.7
1.02
140
825
(3017446) Testosterone [Moles/volume] in Serum or Plasma
125
696
1.86
9.24
2.0
2.2
nmol/l
11.1
13.3
2.31
114
617
(3013826) Glucose [Moles/volume] in Serum or Plasma
846
7170
1.38
9.01
5.5
4.2
mmol/l
6.5
6.6
1.24
789
6602
(3028026) IgM [Mass/volume] in Serum or Plasma
123
692
1.84
8.81
2.4
1.5
g/l
1.4
1.2
0.42
115
640
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
55
227
2.47
8.78
1.9
1.4
u/ml
108.9
109.9
0.02
11
36
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
368
2.15
8.76
2.4
1.4
g/l
3.1
3.0
0.21
67
292
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
630
5127
1.37
8.47
2.1
1.9
pmol/l
97.6
96.8
0.16
318
2622
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
315
2267
1.48
8.45
3.8
3.5
ng/l
529.9
547.1
0.02
223
1607
(3026008) Bacteria identified in Urine by Culture
474
3682
1.41
8.43
2.9
2.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
161
2.72
8.35
2.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
146
881
1.72
8.25
8.1
8.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
63
3.85
8.25
2.4
2.0
%
12.9
11.9
0.17
15
35
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
248
1716
1.53
8.02
1.9
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
64
298
2.19
7.80
2.9
3.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
83
427
1.99
7.79
2.9
1.7
g/l
1.1
1.2
2.82
78
399
(3024731) MCV [Entitic volume]
1581
15256
2.44
7.75
24.7
16.1
fl
90.7
90.6
0.40
1568
15045
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1370
12727
1.49
7.73
5.6
4.8
mu/l
1.8
2.0
0.99
1288
11828
(3007461) Platelets [#/volume] in Blood
1580
15244
2.41
7.72
24.8
16.1
e9/l
255.8
256.7
0.24
1558
14866
(3035941) MCH [Entitic mass]
1581
15258
2.43
7.71
24.6
16.0
pg
30.2
30.2
0.13
1568
15045
(40760892) CBC W Ordered Manual Differential panel - Blood
394
3004
1.41
7.69
5.2
4.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1581
15259
2.43
7.69
24.8
16.1
e12/l
4.5
4.5
2.60
1554
14835
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1513
14387
1.77
7.68
13.3
8.3
u/l
24.8
25.5
0.96
1485
13887
(3010813) Leukocytes [#/volume] in Blood
1581
15262
2.42
7.63
24.8
16.2
e9/l
6.5
6.7
1.62
1555
14839
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
397
2.01
7.55
1.4
1.4
u/l
11.4
9.4
0.47
64
323
(3000963) Hemoglobin [Mass/volume] in Blood
1581
15267
2.41
7.54
24.9
16.2
g/l
134.7
136.0
3.20
1571
15052
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
420
1.98
7.45
2.7
1.8
g/l
1.2
1.5
1.62
74
367
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
59
272
2.21
7.38
1.6
1.6
—
—
—
0
0
(3036489) Thrombin time
89
480
1.90
7.30
2.5
2.0
s
21.8
20.9
0.63
81
413
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
182
1202
1.58
7.23
1.8
1.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1504
14310
1.70
7.19
19.3
11.9
umol/l
77.9
73.2
4.11
1504
14305
(3036481) Cortisol [Moles/volume] in Serum or Plasma
184
1220
1.57
7.18
3.4
1.8
nmol/l
369.9
363.9
0.18
173
1120
(3052851) Hemolysis interference index of Serum or Plasma
67
333
2.06
6.94
2.1
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
143
2.62
6.81
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
269
1955
1.45
6.77
1.5
1.3
titre
488.0
579.8
0.52
50
421
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
180
1209
1.55
6.64
1.9
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
122
2.74
6.62
1.4
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
92
518
1.82
6.62
2.3
1.5
u/ml
8.1
12.7
—
8
10
(3007164) IgA [Mass/volume] in Serum or Plasma
360
2768
1.39
6.57
1.7
1.3
g/l
2.2
2.3
0.51
223
1698
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
472
3789
1.35
6.56
3.7
2.3
u/l
56.5
57.8
0.38
435
3501
(40761511) CBC panel - Blood by Automated count
1495
14246
1.63
6.54
14.5
10.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
76
405
1.92
6.49
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
97
562
1.77
6.36
6.1
3.6
mmol/l
24.0
24.2
0.34
90
505
(3001122) Ferritin [Mass/volume] in Serum or Plasma
730
6253
1.30
6.36
3.7
2.8
ug/l
107.1
93.5
0.89
680
5828
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
156
2.47
6.21
2.9
2.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1287
11945
1.37
6.18
21.7
14.1
g/l
332.3
332.7
1.01
1279
11855
(3014765) Yersinia sp identified in Stool by Organism specific culture
75
408
1.88
6.04
1.2
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
173
1178
1.52
6.00
3.5
2.4
%
1.6
1.8
1.79
163
1046
(3011412) CD3 cells [#/volume] in Blood
25
84
3.01
5.97
2.9
2.6
e9/l
1.1
1.2
0.28
19
45
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1335
12488
1.39
5.92
15.8
9.4
ml/min/173m2
82.5
84.8
2.98
1095
9978
(3048689) Calprotectin [Mass/mass] in Stool
243
1779
1.43
5.84
2.6
2.4
ug/g
97.7
118.6
0.70
196
1394
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
45
3.81
5.82
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
121
765
1.63
5.78
1.3
1.3
iu/l
23.0
26.5
0.61
102
654
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
133
861
1.59
5.77
3.8
3.1
pmol/l
4.5
4.6
0.12
122
759
(42529406) Shigella sp [Presence] in Stool by Culture
75
415
1.85
5.74
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
143
943
1.57
5.73
2.8
2.0
ml/min/173m2
63.6
70.9
1.09
58
361
(40768800) Prostate Pathology biopsy report
17
46
3.72
5.65
1.5
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
153
1028
1.54
5.64
5.7
3.3
mmol/l
1.5
2.0
1.29
135
838
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
7
12.92
5.58
3.2
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
152
2.40
5.57
2.1
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
101
616
1.68
5.55
1.6
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
42
3.84
5.54
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
52
257
2.06
5.53
3.2
3.7
u/ml
0.3
0.4
2.83
28
152
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
394
3149
1.33
5.50
2.5
2.2
mg/l
2.8
2.8
0.04
343
2679
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
47
3.64
5.49
1.3
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
47
3.64
5.49
1.3
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1059
9624
1.29
5.46
3.4
3.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
5
16.07
5.41
2.1
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
5
16.07
5.41
1.9
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
34
4.14
5.36
6.9
4.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
68
3.12
5.35
2.9
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
44
207
2.16
5.32
5.5
2.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
222
1631
1.42
5.23
1.9
1.6
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
8
6
13.39
5.08
5.4
2.3
mg/l
19.4
19.5
—
8
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
152
1044
1.50
5.07
5.4
3.3
kpa
5.9
5.8
0.24
146
1013
(3014111) Lactate [Moles/volume] in Serum or Plasma
136
914
1.53
5.03
6.4
6.8
mmol/l
1.2
1.3
1.57
130
879
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
261
1.98
4.96
4.0
1.4
mg/l
71.4
42.0
0.39
38
212
(3023520) Reticulocytes [#/volume] in Blood
127
844
1.55
4.94
3.8
2.5
e9/l
65.1
70.3
1.14
92
643
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
262
1.98
4.91
4.0
1.4
mg/l
31.6
55.1
0.54
38
212
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
79
2.81
4.72
1.1
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
53
281
1.92
4.68
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
162
1148
1.46
4.64
5.8
8.0
mmol/l
0.5
1.2
1.45
126
888
(3016502) Oxygen saturation in Arterial blood
147
1022
1.48
4.64
5.8
8.5
%
96.4
95.3
1.42
140
990
(3005322) IgE [Units/volume] in Serum or Plasma
141
974
1.49
4.59
1.3
1.3
u/ml
156.5
217.6
0.74
133
898
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
339
2717
1.31
4.56
1.5
1.5
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
9
11
8.22
4.56
3.1
3.2
—
12.1
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
22
81
2.74
4.52
2.4
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
18
59
3.07
4.52
1.6
1.2
u/l
100.1
78.8
0.51
18
52
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
123
2.38
4.50
2.5
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
449
3741
1.28
4.48
2.2
2.1
u/l
186.3
210.0
0.26
418
3523
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
50
264
1.92
4.48
1.5
1.2
u/ml
293.0
229.6
0.60
37
153
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
30
4.02
4.44
2.5
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
24
94
2.58
4.39
3.2
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
52
281
1.88
4.36
1.5
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
44
225
1.98
4.33
4.4
3.7
%
59.1
57.3
0.56
44
225
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
205
2.03
4.29
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
205
2.03
4.29
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
34
158
2.18
4.29
1.7
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
161
1159
1.43
4.25
5.8
7.9
kpa
4.9
5.1
1.49
152
1111
(3049717) Cytology report of Urine Cyto stain
54
298
1.84
4.25
2.1
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
96
2.52
4.22
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1344
12750
1.32
4.16
18.9
11.9
%
40.0
40.0
0.13
1051
9612
(3024980) IgG subclass 4 [Mass/volume] in Serum
41
208
2.00
4.14
1.8
1.7
g/l
0.6
0.9
0.77
32
154
(3027801) Oxygen [Partial pressure] in Arterial blood
160
1159
1.42
4.09
5.8
7.9
kpa
12.7
12.1
0.75
151
1112
(3002173) Hemoglobin [Mass/volume] in Arterial blood
134
941
1.46
4.04
6.2
8.8
g/l
118.5
122.9
1.44
129
906
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
69
416
1.69
4.03
3.5
1.7
g/l
0.2
0.2
1.33
64
392
(3003327) Ova and parasites identified in Stool by Light microscopy
74
455
1.66
4.02
1.8
1.8
—
—
—
0
0
(4010399)
134
943
1.46
4.00
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
40
204
1.99
3.99
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
586
5091
1.24
3.98
4.1
3.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
279
2217
1.31
3.97
4.7
3.5
%
25.1
24.0
0.46
130
964
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
981
8997
1.23
3.93
3.7
2.8
u/l
41.4
39.9
0.30
927
8459
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
58
336
1.75
3.91
1.6
2.1
mg/l
11.4
11.2
0.06
53
309
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
95
626
1.55
3.89
2.4
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
364
3005
1.27
3.85
2.0
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
42
221
1.92
3.84
4.0
3.5
e9/l
3.9
4.1
0.26
42
221
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
126
2.24
3.84
1.9
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
373
3091
1.27
3.82
3.1
2.9
ng/l
1406.1
1155.0
0.46
311
2584
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
101
2.40
3.82
2.0
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
22
89
2.49
3.80
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
204
1561
1.35
3.76
3.4
2.6
ug/l
0.7
0.7
0.31
149
970
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
115
2.28
3.72
3.4
1.8
u/ml
41.7
40.7
0.01
26
101
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
85
553
1.57
3.69
1.8
1.9
u/l
39.9
38.8
0.23
72
495
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
40
210
1.93
3.69
1.4
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
392
3281
1.26
3.68
1.4
1.3
u/ml
1.1
1.6
0.60
111
887
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
45
3.13
3.65
3.4
2.2
ug/l
68.9
69.1
0.00
14
45
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
30
3.68
3.64
2.6
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
110
760
1.48
3.63
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
355
2943
1.26
3.61
2.3
1.7
mg/l
0.9
1.0
0.66
258
2206
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1420
13636
1.33
3.57
5.1
4.6
mmol/l
2.8
2.8
0.65
1343
12709
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
172
2.00
3.50
1.5
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
6
6
10.03
3.50
3.0
4.7
u/l
307.5
734.3
—
6
6
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1347
12852
1.28
3.49
4.1
3.8
mmol/l
1.2
1.3
1.97
1266
11920
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
132
2.14
3.46
1.9
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
333
2755
1.26
3.44
5.2
3.6
ug/l
2.0
1.8
0.87
305
2489
(3026389) Candida sp identified in Specimen by Organism specific culture
33
167
2.00
3.40
1.2
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
33
167
2.00
3.40
3.4
1.6
iu/ml
60.5
25.4
—
6
8
(4034850)
22
468
0.46
3.35
5.0
9.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
59
2.73
3.32
1.6
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
36
190
1.92
3.30
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
41
226
1.84
3.30
2.1
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
63
393
1.63
3.29
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
138
1014
1.39
3.29
3.4
3.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
7
8.60
3.26
1.8
2.4
mg/l
6.7
4.2
—
6
7
(3024928) Oxygen saturation in Venous blood
43
242
1.80
3.25
3.8
2.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
128
931
1.41
3.24
5.6
4.2
%
1.1
0.7
0.98
33
184
(3019150) Specific gravity of Urine by Refractometry
351
2941
1.25
3.23
3.9
3.7
kg/l
1.0
1.0
0.09
46
431
(40768441) Liver Pathology biopsy report
17
66
2.59
3.21
1.5
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
66
2.59
3.21
1.2
1.1
miu/ml
1583.8
1653.7
0.08
17
66
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
96
663
1.48
3.20
1.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
147
1098
1.37
3.18
1.3
1.2
iu/ml
104.9
142.1
0.79
54
433
(3048929) Epstein Barr virus Ab [Presence] in Serum
71
461
1.56
3.15
1.5
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
222
1765
1.30
3.14
1.4
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
20
4.52
3.11
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
35
188
1.88
3.07
4.4
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
433
1.57
3.05
1.4
1.6
iu/ml
0.7
0.2
0.35
15
85
(3024354) Oxygen [Partial pressure] in Venous blood
120
873
1.40
3.05
4.5
2.7
kpa
4.7
4.6
0.24
115
846
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
417
3580
1.22
3.04
1.7
1.7
mmol/l
1.4
1.4
0.06
377
3060
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
106
2.19
3.03
6.1
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
123
902
1.39
2.99
5.7
4.3
%
0.3
0.1
1.15
32
169
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
234
1.77
2.98
2.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
194
1531
1.30
2.91
6.3
5.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
112
812
1.41
2.91
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
207
1.81
2.88
3.8
3.2
—
—
—
0
0
(44806118)
25
123
2.05
2.82
2.2
1.4
—
—
—
0
0
(44790049)
25
123
2.05
2.82
2.2
1.4
—
—
—
0
0
(44790048)
25
123
2.05
2.82
2.2
1.4
—
—
—
0
0
(44790047)
25
123
2.05
2.82
2.2
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
118
869
1.39
2.81
5.7
4.3
%
0.0
0.7
0.55
28
152
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
386
1.58
2.80
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
52
323
1.63
2.80
1.6
1.4
ug/g
247.5
313.3
1.46
28
178
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
77
524
1.49
2.80
7.3
9.9
mmol/l
24.1
24.4
0.31
71
490
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
173
1.87
2.78
1.9
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
124
2.03
2.76
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
264
2182
1.25
2.73
1.7
1.7
nmol/l
1192.0
1170.4
0.13
201
1669
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
111
2.09
2.73
1.8
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
98
2.16
2.71
2.4
2.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
136
1032
1.35
2.69
1.6
1.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
47
288
1.65
2.68
1.4
1.4
pmol/l
81.2
52.7
0.59
47
281
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
99
2.14
2.65
1.9
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
67
2.40
2.63
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
399
3459
1.20
2.60
4.5
3.6
estimate
0.0
0.0
1.08
133
1155
(3047189) Immunofixation for 24 hour Urine
9
25
3.61
2.57
1.3
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
68
2.37
2.56
1.9
1.5
u/l
2.4
8.7
—
8
32
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
50
2.61
2.53
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
74
512
1.47
2.51
6.6
12.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1384
13362
1.24
2.50
4.5
4.2
mmol/l
1.5
1.5
1.47
1315
12458
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1391
13438
1.25
2.49
4.6
4.2
mmol/l
4.7
4.7
0.34
1322
12589
(4281824)
16
69
2.33
2.48
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
16
4.39
2.47
2.0
1.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
21
3.82
2.46
2.1
1.4
ng/l
192.1
87.2
—
8
21
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
188
1.77
2.46
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
96
2.10
2.43
1.8
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
90
2.12
2.39
2.8
1.8
%
11.7
10.7
0.42
19
90
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
40
2.76
2.37
1.2
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
22
3.65
2.36
3.0
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
114
861
1.35
2.36
5.0
4.1
%
0.6
0.4
0.40
26
142
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
96
707
1.38
2.33
4.1
3.7
kpa
5.1
5.2
0.60
86
668
(3016018) Differential panel - Cerebral spinal fluid
25
133
1.89
2.32
1.3
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
81
580
1.42
2.31
1.3
1.2
u/ml
0.2
1.1
—
7
47
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
215
1.69
2.30
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
331
2852
1.20
2.29
1.5
1.5
nmol/l
22.0
21.1
0.50
283
2443
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
94
693
1.38
2.27
2.3
2.2
u/l
5437.3
4132.3
0.17
37
298
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
23
3.49
2.27
2.5
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
20
99
2.03
2.26
2.0
1.5
g/l
1.0
1.0
0.12
20
99
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
287
2443
1.21
2.25
1.8
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
125
965
1.32
2.24
2.2
2.4
ug/l
6.5
7.2
0.19
107
846
(3034770) Mitochondria Ab [Titer] in Serum
51
335
1.54
2.24
1.5
1.2
—
1171.8
—
0
11
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1352
13057
1.21
2.22
4.6
4.2
mmol/l
5.8
5.8
0.75
1269
12022
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
60
2.34
2.22
1.6
1.4
e6/l
91737.5
147710.3
—
8
33
(3024932) HLA-DR beta [Type]
10
36
2.79
2.20
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
54
2.42
2.20
1.6
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
161
1291
1.27
2.18
1.8
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
294
2519
1.20
2.16
1.3
1.3
iu/ml
40.0
33.3
0.16
89
793
(3013139) Helicobacter pylori Ag [Presence] in Stool
118
911
1.32
2.13
1.2
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
38
236
1.62
2.12
1.1
1.1
au/ml
5.3
11.9
—
5
14
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
68
2.22
2.11
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
10
37
2.71
2.10
1.0
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
229
1.63
2.09
1.7
1.3
nmol/l
0.4
0.4
0.25
28
196
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
214
1.65
2.07
1.1
1.1
u/ml
2.4
2.0
0.12
20
97
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
103
1.95
2.05
1.3
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1267
12189
1.18
2.05
5.7
5.4
mmol/mol
38.6
39.3
1.69
1189
11401
(3012441) Differential panel - Pleural fluid
13
56
2.33
2.05
1.6
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
93
698
1.35
2.04
4.2
3.6
ph
7.4
7.4
—
10
79
(36660697) Celiac disease serology panel - Serum
147
1177
1.27
2.03
1.3
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
11
44
2.51
2.01
1.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
38
2.64
2.01
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
38
2.64
2.01
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
79
579
1.38
2.01
1.7
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
66
469
1.42
2.00
4.2
4.0
mmol/l
24.4
24.8
0.56
61
438
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
21
3.34
1.96
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
677
1.35
1.95
4.2
3.6
mmol/l
1.3
1.6
0.35
67
500
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
210
1.63
1.95
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
210
1.63
1.95
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
334
2921
1.18
1.95
1.7
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
51
2.36
1.95
2.1
2.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
58
405
1.45
1.94
1.1
1.1
u/ml
3.2
6.2
0.45
11
55
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
16
3.76
1.93
1.3
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
39
2.57
1.92
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
129
1026
1.28
1.89
1.5
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
121
1.83
1.88
1.4
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
280
2420
1.19
1.87
1.3
1.3
u/ml
10.0
11.0
0.09
96
973
(3035320) C reactive protein [Mass/volume] in Body fluid
17
86
1.99
1.85
1.6
2.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
168
1384
1.24
1.83
30.9
23.0
inr
1.6
1.3
0.84
25
217
(3025130) Human papilloma virus identified in Specimen
36
230
1.58
1.82
1.8
1.8
—
—
—
0
0
(1002224) Polysomnography panel
81
608
1.35
1.80
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
80
2.01
1.80
1.4
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
14
67
2.10
1.76
1.6
1.3
e6/l
2560.1
2492.4
—
8
46
(1761482) Bacteria [#/volume] in Urine by Culture
43
289
1.50
1.75
2.9
3.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
18
3.34
1.74
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
186
1.62
1.73
1.6
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
34
218
1.57
1.71
3.1
3.5
mmol/l
2.2
2.6
0.45
25
134
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
104
1.84
1.67
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
84
643
1.32
1.66
6.5
7.7
mmol/l
24.1
24.6
0.63
78
598
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
18
97
1.87
1.66
1.4
1.1
iu/ml
13.4
15.0
—
6
22
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
19
3.17
1.66
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
212
1.57
1.66
1.4
1.2
u/ml
2.1
6.0
1.71
15
91
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
492
4483
1.14
1.64
3.6
3.3
ng/l
28.6
47.7
1.19
288
2747
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
61
445
1.39
1.64
1.5
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
112
893
1.27
1.64
1.4
1.3
au/ml
88.7
37.7
—
5
41
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
14
3.58
1.61
3.6
3.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
123
995
1.26
1.60
2.6
2.3
au/ml
24.0
19.8
—
7
58
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
14
70
2.01
1.59
2.1
1.7
u/field
2.8
2.9
—
9
54
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
20
3.01
1.58
1.3
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
77
587
1.33
1.58
1.5
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
50
2.21
1.57
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
27
168
1.62
1.55
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
54
390
1.40
1.55
1.5
2.0
iu/l
2.6
5.0
4.02
11
147
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
57
2.11
1.55
3.6
2.7
u/ml
570.3
866.9
0.62
12
57
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
105
840
1.27
1.51
6.4
2.6
mmol/l
1.2
1.2
0.25
93
703
(21494814) CD8 cells/100 lymphocytes in Specimen
7
27
2.60
1.51
3.0
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
41
283
1.46
1.51
1.2
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
21
2.86
1.50
1.3
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
318
1.43
1.47
1.4
1.4
e6/l
223.6
1826.2
1.11
35
268
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
318
1.43
1.47
1.4
1.3
e6/l
20.6
35.9
0.28
34
256
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
38
2.38
1.45
1.2
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
28
2.51
1.45
1.3
1.1
u/ml
46.4
44.9
—
7
28
(3003694) ABO and Rh group [Type] in Blood
410
3720
1.14
1.45
1.5
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
37
253
1.47
1.43
1.6
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
132
1092
1.23
1.43
3.6
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
68
518
1.33
1.42
4.2
3.7
—
—
—
0
0
(4306422)
32
213
1.51
1.41
1.1
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
96
1.78
1.39
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
71
547
1.31
1.38
1.6
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
89
1.81
1.37
1.8
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
23
143
1.62
1.35
1.4
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
24
151
1.60
1.35
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
398
3621
1.13
1.35
3.7
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
84
665
1.28
1.34
4.0
5.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
105
1.72
1.33
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
105
1.72
1.33
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
105
1.72
1.33
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
24
2.51
1.30
1.3
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
57
430
1.34
1.30
1.7
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
24
153
1.58
1.29
1.2
1.3
nmol/l
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
37
260
1.43
1.27
1.6
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
107
1.69
1.26
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
107
1.69
1.26
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
107
1.69
1.26
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
45
2.01
1.23
2.0
1.2
—
—
—
0
0
(3013512) EKG study
370
3380
1.12
1.17
3.7
3.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
110
916
1.22
1.16
2.9
2.8
ng/l
127.2
175.8
1.74
104
838
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
95
1.69
1.14
1.3
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
573
0.74
1.13
2.2
1.9
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
30
2.34
1.12
1.0
1.2
—
72.1
—
0
7
(4268621)
22
143
1.55
1.11
2.5
2.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
127
1.58
1.11
1.3
1.6
—
—
—
0
0
(4062490)
21
135
1.56
1.11
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
52
398
1.32
1.10
1.5
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
195
1715
1.16
1.10
1.7
1.7
%
1.4
1.4
1.09
171
1529
(3000475) Leukocytes [#/volume] in Synovial fluid
40
294
1.37
1.10
2.2
1.7
e6/l
7419.0
11860.7
0.62
27
228
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
96
1.67
1.10
1.3
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
31
218
1.43
1.09
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
33
235
1.41
1.09
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
41
1.96
1.09
3.6
9.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
130
1515
0.85
1.06
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
33
2.13
1.05
2.4
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
2.4
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
2.4
1.7
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
67
1.80
1.04
1.1
1.3
—
73.3
—
0
9
(3002619) Bacteria identified in Specimen by Culture
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
114
1.59
1.02
1.1
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
433
4020
1.11
1.02
4.3
3.2
mmol/l
7.1
7.6
1.36
381
3440
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
9
47
1.92
1.02
1.0
1.1
%
103.3
120.2
—
9
42
(3025577) Chromium [Mass/volume] in Blood
12
68
1.77
1.00
2.5
2.0
ug/l
2.1
2.0
0.01
12
58
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
115
1.57
0.99
1.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
240
1.38
0.99
2.4
2.3
g/l
129.9
134.4
0.33
20
178
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
223
1.40
0.99
1.3
1.2
u/ml
7.1
3.7
—
8
71
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
29
0.00
0.97
0.0
1.1
—
72.7
—
0
22
(3000492) Spirometry study
151
1318
1.16
0.97
1.8
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
54
1.86
0.96
1.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
12
70
1.72
0.92
2.6
2.0
ug/l
3.5
3.4
0.04
12
64
(3032773) Endomysium IgG Ab [Titer] in Serum
20
134
1.50
0.92
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
28
2.15
0.91
1.3
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
126
1.51
0.91
1.4
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
86
1.63
0.91
2.2
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
86
1.63
0.91
2.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
86
1.63
0.91
2.2
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
29
2.07
0.89
5.0
2.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
43
1.86
0.87
1.3
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
43
1.86
0.87
1.0
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
255
1.34
0.87
2.6
3.0
mmol/l
24.9
24.9
0.01
25
230
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
137
1559
0.87
0.86
4.5
4.4
%
31.9
32.4
0.20
103
1078
(4133840)
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
387
3609
1.09
0.83
4.6
3.3
mg/l
913.3
200.9
1.19
253
2250
(3045414) Leukocytes [Presence] in Urine
70
580
1.22
0.83
1.8
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
46
1.74
0.82
2.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
46
1.74
0.82
2.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
46
1.74
0.82
2.3
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
46
1.74
0.82
2.3
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
38
293
1.30
0.82
1.0
1.1
u/ml
1.0
2.0
—
9
77
(3021901) Oxygen saturation in Capillary blood
24
172
1.40
0.81
2.7
2.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
147
1.43
0.80
1.3
1.4
pmol/l
477.7
332.1
0.55
15
107
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
303
1.29
0.80
3.5
2.3
ug/min
69.4
91.9
0.28
28
192
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
48
1.67
0.78
2.3
2.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
107
928
1.16
0.78
2.3
2.5
e9/l
4.6
4.1
0.61
81
733
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
182
1.38
0.78
3.6
3.3
nmol/l
0.8
0.8
0.33
19
141
(44806420)
0
28
0.00
0.76
0.0
2.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
149
1.41
0.75
1.5
1.3
—
—
—
0
0
(4027681)
15
99
1.52
0.75
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
218
1.34
0.75
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
333
1.27
0.75
1.7
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
75
1.60
0.75
1.2
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
404
3796
1.09
0.74
5.3
4.0
mg/mmol
11.0
9.2
0.38
263
2374
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
343
1.26
0.73
1.0
1.1
u/ml
5.1
1.8
0.39
16
144
(3045424) Erythrocytes [Presence] in Urine
27
202
1.34
0.72
1.6
1.5
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
56
1.61
0.72
1.4
1.1
%
112.7
112.0
—
9
46
(3024891) Influenza virus A+B Ag [Presence] in Specimen
44
353
1.25
0.72
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
40
1.75
0.71
1.4
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
292
1.27
0.69
1.4
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
10
61
1.64
0.68
3.8
1.7
—
18.7
—
0
6
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
43
1.63
0.67
1.3
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
28
1.79
0.66
5.0
5.2
—
—
—
0
0
(3036603) Volume of Urine
11
70
1.58
0.65
1.1
1.5
—
1982.4
—
0
14
(3037121) Protein [Mass/volume] in Urine
47
386
1.22
0.64
3.1
3.0
g/l
0.2
0.3
0.39
20
139
(3020891) Body temperature
51
423
1.21
0.64
6.2
4.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
217
1.30
0.62
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
96
1.46
0.61
1.3
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
122
1.40
0.60
2.4
1.7
pg
31.5
32.7
0.56
17
122
(1761868) Lipid panel - Serum or Plasma
482
5049
0.94
0.60
2.7
2.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
80
1.50
0.59
1.5
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
52
1.54
0.59
1.5
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
35
432
0.81
0.59
1.3
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
72
1.53
0.59
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
72
1.53
0.59
1.3
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
24
310
0.77
0.59
1.9
2.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
57
483
1.19
0.58
4.8
3.3
%
51.5
48.0
0.47
57
473
(3008898) HLA-B27 [Presence]
65
558
1.17
0.58
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
106
1.42
0.57
1.6
1.5
%
23.6
32.7
—
10
68
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
132
1.37
0.57
1.5
2.5
mg/l
30.0
26.6
—
6
34
(3043238) Trisomy 21 risk [Likelihood] in Fetus
36
440
0.81
0.56
1.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
35
429
0.81
0.56
1.3
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
46
384
1.20
0.56
1.5
1.2
u/ml
15.5
2.9
—
6
40
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
65
560
1.17
0.56
1.3
1.3
miu/ml
249.5
237.3
0.11
36
282
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
55
1.46
0.56
1.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
37
1.62
0.55
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
37
1.62
0.55
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
90
1.45
0.55
4.9
3.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
72
629
1.15
0.53
3.0
3.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
143
1.33
0.52
1.7
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
28
223
1.26
0.52
2.0
1.3
u/l
35.2
24.4
0.64
23
174
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
223
1.26
0.52
1.2
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
63
1.43
0.52
1.8
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
98
0.61
0.52
1.2
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
41
1.47
0.50
3.7
3.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
49
571
0.85
0.48
1.4
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
391
1.18
0.48
1.5
1.2
u/ml
3.9
7.3
—
8
68
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
45
527
0.85
0.47
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
47
1.49
0.47
1.3
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
102
1.38
0.47
2.2
2.3
u/field
2.0
2.2
—
6
50
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
137
1.32
0.47
1.8
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
48
1.46
0.46
1.3
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
45
526
0.85
0.46
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
73
646
1.14
0.46
1.5
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
209
1.25
0.46
2.9
2.3
%
15.7
17.0
0.70
14
101
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
45
525
0.85
0.46
1.4
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
49
1.43
0.46
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
49
1.43
0.46
2.4
2.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
49
1.43
0.46
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
138
1.31
0.45
1.8
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
45
524
0.85
0.45
1.4
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
22
174
1.27
0.45
1.4
1.3
nmol/l
0.6
0.6
0.35
22
164
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
12
86
1.40
0.44
1.3
1.4
—
1.5
—
0
5
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
139
1.30
0.43
1.8
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
88
794
1.11
0.42
1.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
32
1.56
0.42
2.2
1.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
70
1.43
0.41
1.6
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
5
33
1.52
0.41
1.0
1.2
—
2.3
—
0
6
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
26
213
1.22
0.41
1.2
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
34
1.47
0.40
1.2
1.3
%
63.6
50.4
—
5
29
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
141
1.28
0.40
1.8
1.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
18
0.00
0.40
0.0
1.3
—
5.5
—
0
10
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
28
232
1.21
0.40
1.3
1.2
ug/l
2.9
3.0
0.09
23
218
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
61
1.31
0.39
1.5
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
71
1.41
0.39
1.0
1.5
nmol/l
151.0
141.3
—
10
71
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
142
1.27
0.38
1.8
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
161
1.25
0.37
1.5
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
277
2643
1.06
0.36
1.7
1.7
pmol/l
21519447.9
41011158.2
0.36
237
2236
(21494434) Karyotype in Bone marrow
11
81
1.36
0.36
1.2
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
38
328
1.16
0.36
3.7
8.1
mmol/l
1.2
1.3
0.23
31
286
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
99
1.32
0.35
1.2
1.1
u/l
0.9
1.1
—
5
45
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
82
1.34
0.34
1.1
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
15
118
1.27
0.33
1.1
1.6
mosm/kgh2o
281.2
280.6
—
10
88
(3014051) Protein [Presence] in Urine by Test strip
26
306
0.85
0.32
2.3
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
74
1.35
0.32
1.1
1.2
—
—
—
0
0
(4146454)
10
132
0.76
0.32
2.7
2.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
200
1901
1.06
0.31
2.0
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
53
1.32
0.31
1.3
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
54
1.30
0.30
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
129
1.24
0.30
1.4
1.2
u/ml
1.1
0.7
—
9
55
(4094501)
40
353
1.14
0.30
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
111
1.26
0.30
3.2
2.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
55
1.27
0.30
2.4
2.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
102
1.28
0.30
2.3
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
114
1065
1.08
0.29
5.8
3.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
43
382
1.13
0.29
5.0
3.7
mmol/l
1.2
1.4
1.12
43
377
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
108
0.74
0.29
1.0
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
63
1.27
0.27
1.1
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
279
0.86
0.27
2.3
3.5
mg/l
11.9
25.0
3.34
13
179
(3022621) pH of Urine by Test strip
81
872
0.93
0.26
2.5
2.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
34
301
1.13
0.25
1.6
1.2
—
10.9
—
0
5
(44813793)
13
105
1.24
0.24
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
220
2116
1.05
0.24
2.2
2.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
115
1.22
0.23
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
155
1623
0.95
0.23
1.5
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
39
1.28
0.23
1.2
1.0
—
—
—
0
0
(3019225) pH of Specimen
107
1132
0.94
0.22
6.9
3.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
10
79
1.27
0.22
1.3
1.3
umol/l
26.3
23.2
—
10
74
(3051339) Copper [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
16.1
—
0
10
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
212
1.13
0.19
1.3
1.4
mmol/l
6.2
7.6
1.33
16
150
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
462
1.08
0.19
3.0
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
52
1.15
0.19
1.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
52
1.15
0.19
2.0
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
92
970
0.95
0.18
1.5
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
59
1.19
0.18
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
61
1.15
0.17
5.0
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
27
243
1.11
0.17
3.5
2.6
mmol/l
1.4
1.5
0.47
27
233
(3038515) Glucose [Moles/volume] in Venous blood
25
224
1.12
0.17
3.7
2.7
mmol/l
6.8
7.3
0.34
25
215
(3021788) Differential panel - Synovial fluid
25
224
1.12
0.17
1.6
1.6
—
—
—
0
0
(4211845)
8
70
1.14
0.16
4.3
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.3
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
40
432
0.92
0.16
1.6
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
254
1.10
0.16
1.0
1.0
u/ml
4.1
3.6
0.09
11
103
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
313
1.09
0.15
1.1
1.1
u/ml
5.5
6.0
0.06
19
175
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
95
992
0.96
0.14
1.5
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
489
1.07
0.14
2.1
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
160
1.13
0.14
1.8
1.6
%
55.0
58.9
—
10
110
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
296
1.08
0.13
1.4
1.3
—
—
—
0
0
(4024509)
13
113
1.15
0.13
1.7
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
123
1.14
0.12
3.5
2.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
191
1.10
0.11
1.7
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
124
1.13
0.11
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
174
1699
1.03
0.11
1.6
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
270
1.08
0.10
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
187
0.91
0.10
1.4
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
282
1.07
0.09
3.1
2.2
nmol/l
0.8
0.8
0.12
23
228
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
42
400
1.05
0.08
1.5
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
302
1.06
0.08
1.0
1.1
u/ml
0.5
1.0
0.77
15
137
(3006462) Nitrate [Presence] in Urine
7
64
1.09
0.08
4.7
3.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
236
0.93
0.08
2.6
1.9
umol/l
7.6
4.6
0.59
17
168
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
73
0.82
0.07
4.2
2.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
75
0.80
0.07
1.7
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
108
1.11
0.07
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
46
475
0.97
0.05
1.6
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
11
120
0.92
0.05
1.7
1.4
nmol/l
1.5
1.5
0.05
11
103
(3005570) Glucose [Moles/volume] in Urine
12
130
0.92
0.04
2.8
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
26
249
1.04
0.04
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
183
1811
1.01
0.04
1.7
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
141
1393
1.01
0.03
1.8
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
230
0.96
0.03
1.0
1.1
u/ml
11.7
5.0
—
10
98
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
25
241
1.04
0.02
1.3
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
38
371
1.02
0.02
1.4
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
47
461
1.02
0.02
1.7
2.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
252
1.03
0.02
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
157
0.95
0.01
1.1
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
104
1.06
0.01
17.4
13.5
nmol/l
895.3
820.7
0.20
11
99
(1001926) Buprenorphine [Presence] in Urine by Screen method
53
524
1.01
0.00
1.6
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
108
1.02
0.00
1.5
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
142
0.99
0.00
1.1
1.5
mmol/l
8.5
12.8
—
6
28
(3023419) Bacteria identified in Sputum by Culture
15
148
1.01
0.00
2.8
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
61
614
0.99
0.00
1.5
2.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
11
111
0.99
0.00
1.8
1.1
—
63.9
—
0
8
(3000764) Benzodiazepines [Presence] in Urine
65
652
1.00
0.00
1.5
2.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
62
618
1.00
0.00
1.5
1.6
mg/l
3.0
4.4
0.61
37
421
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
19
191
0.99
0.00
1.2
1.2
u/l
26.2
20.1
0.19
12
162
(3001019) Free T4 and TSH panel - Serum or Plasma
89
892
1.00
0.00
1.6
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
651
1.00
0.00
1.5
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
97
1.03
0.00
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
66
657
1.00
0.00
1.5
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
95
1.05
0.00
1.8
1.4
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
17.0
—
0
6
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
5
55
0.91
0.00
1.4
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
66
660
1.00
0.00
1.5
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
92
0.98
0.00
2.4
1.2
—
—
—
0
0
(4198724)
6
68
0.88
0.00
1.3
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
170
1.00
0.00
1.8
1.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
86
0.93
0.00
1.5
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
5.7
—
0
7
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_LOWERLIMB_EXALLC – Melanocytic naevi of lower limb, including hip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).